Северного Кавказа
по надзору за соблюдением законодательства
в сфере массовых коммуникаций
и охране культурного наследия
ПИ №ФС77-26521 от 7 декабря 2006 года
ISSN 2073-8137
русский
english
Поиск по сайту
Адрес редакции
355017, Ставрополь, улица Мира, 310.
Телефоны
(8652) 35-25-11, 35-32-29.
E-mail
medvestnik@stgmu.ru
Журнал включён в Перечень ведущих рецензируемых научных журналов и изданий, в которых должны быть опубликованы результаты диссертаций на соискание учёной степени кандидата и доктора наук (решение Президиума ВАК Минобрнауки РФ №6/6, февраль 2010).
Журнал включён в Реферативный журнал и Базы данных ВИНИТИ РАН и зарегистрирован в Научной электронной библиотеке в базе данных Российского индекса научного цитирования на основании сублицензионного договора № 07-04/09-14 от 25 марта 2009 года.
Журнал индексируется: БД SCOPUS, Ulrich's International Periodicals Directory.
Взаимосвязь гипогликемии с повышенным риском развития инсульта у больных сахарным диабетом 2-го типа старших возрастных групп
[Обзоры]
Остроумова Ольга Дмитриевна; Стародубова Антонина Владимировна; Кочетков Алексей Иванович; Дё Валерия Анатольевна; Остроумова Татьяна Максимовна; Кикнадзе Тамара Давидовна;
Рассматривается проблема гипогликемических состояний у больных сахарным диабетом 2-го типа и взаимосвязь гипогликемии с риском развития инсульта. Представлены данные о влиянии различных сахароснижающих лекарственных средств на шансы формирования острого нарушения мозгового кровообращения. Описаны механизмы, опосредующие взаимосвязь гипогликемиии и инсульта с позиций активации симпатоадреналовой нервной системы, индукции коагуляционного гемостаза, агрегации тромбоцитов, стимуляции свободнорадикального окисления, возникновения эндотелиальной дисфункции.
Список литературы:
1. Cosentino F., Grant P. J., Aboyans V., Bailey C. J., Ceriello A. [et al.]. ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart J. 2019;00:1-69, pii: ehz486. https://doi.org/10.1093/eurheartj/ehz486
2. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под редакцией И. И. Дедова, М. В. Шестаковой, А. Ю. Майорова. 9-й выпуск. М.: УП ПРИНТ, 2019. https://doi.org/10.14341/DM221S1
3. O’Donnell M. J., Xavier D., Liu L., Zhang H., Chin S. L. [et al.]. INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112-123. https://doi.org/10.1016/S0140-6736(10)60834-3
4. Sarwar N., Gao P., Seshasai S. R., Gobin R., Kaptoge S. [et al.]. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-2222. https://doi.org/10.1016/S0140-6736(10)60484-9
5. Kuusisto J., Mykkänen L., Pyörälä K., Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 1994;25(6):1157-1164. https://doi.org/10.1161/01.STR.25.6.1157
6. Aronow W. S., Ahn C. Risk factors for new atherothrombotic brain infarction in older Hispanic men and women. J. Gerontol. A. Biol. Sci. Med. Sci. 2002;57(1):M61-M63. https://doi.org/10.1093/gerona/57.1.m61
7. Buehler A. M., Cavalcanti A. B., Berwanger O., Figueiro M., Laranjeira L. N. [et al.]. Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Cardiovasc. Ther. 2013;31(3):147-160. https://doi.org/10.1111/j.1755-5922.2011.00308.x
8. Smith L., Chakraborty D., Bhattacharya P., Sarmah D. Koch S., Dave K. R. Exposure to hypoglycemia and risk of stroke. Ann. N. Y. Acad. Sci. 2018;1431(1):25-34. https://doi.org/10.1111/nyas.13872
9. Exton J. H. Mechanisms of hormonal regulation of hepatic glucose metabolism. Diabetes Metab. Rev. 1987;3(1):163-183. https://doi.org/10.1002/dmr.5610030108
10. Hanefeld M., Duetting E., Bramlage P. Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review. Cardiovasc. Diabetol. 2013;12:135. https://doi.org/10.1186/1475-2840-12-135
11. Segel S. A., Paramore D. S., Cryer P. E. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes. 2002;51(3):724-733. https://doi.org/10.2337/diabetes.51.3.724
12. Joy N. G., Tate D. B., Younk L. M., Davis S. N. Effects of acute and antecedent hypoglycemia on endothelial function and markers of atherothrombotic balance in healthy humans. Diabetes. 2015;64(7):2571-2580. https://doi.org/10.2337/db14-1729
13. Dalsgaard-Nielsen J., Madsbad S., Hilsted J. Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjects. Thromb. Haemost. 1982;47(3):254-258. https://doi.org/10.1055/s-0038-1657180
14. Rathmann W., Kostev K., Gruenberger J. B., Dworak M., Bader G., Giani G. Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patientswith dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis. Diabetes Obes. Metab. 2013;15(1):55-61. https://doi.org/10.1111/j.1463-1326.2012.01674.x
15. Gitt A. K., Bramlage P., Binz C., Krekler M., Deeg E., Tschöpe D. Prognostic implications of DPP-4 inhibitor vs. sulfonylurea use on top of metformin in a real world setting – results of the 1 year follow-up of the prospective DiaRegis registry. Int. J. Clin. Pract. 2013;67(10):1005-1014. https://doi.org/10.1111/ijcp.12179
16. Nunes A. P., Iglay K., Radican L., Engel S. S., Yang J. [et al.]. Hypoglycemia seriousness and weight gain as determinants of cardiovascular disease outcomes among sulfonylurea users. Diabetes Obes. Metab. 2017;19(10):1425-1435. https://doi.org/10.1111/dom.13000
17. Pieber T. R., Marso S. P., McGuire D. K., Pieber T. R., Marso S. P. [et al.]. DEVOTE Study Group. DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality. Diabetologia. 2018;61(1):58-65. https://doi.org/10.1007/s00125-017-4422-0
18. Heller S. R., Bergenstal R. M., White W. B., Kupfer S., Bakris G. L. [et al.]. EXAMINE Investigators. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial. Diabetes Obes. Metab. 2017;19(5):664-671. https://doi.org/10.1111/dom.12871
19. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N. [et al.]. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 2009;360(2):129-139. https://doi.org/10.1056/NEJMoa0808431
20. Lee A. K., Warren B., Lee C. J., McEvoy J. W., Matsushita K. [et al.]. The association of severe hypoglycemia with incident cardiovascular events and mortality in adults with type 2 diabetes. Diabetes Care. 2018;41(1):104-111. https://doi.org/10.2337/dc17-1669
21. Advance Collaborative Group, Patel A., MacMahon S., Chalmers J., Neal B., Billot L. [et al.]. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 2008;358(24):2560-2572. https://doi.org/10.1056/NEJMoa0802987
22. Gerstein H. C., Miller M. E., Byington R. P., Goff D. C. Jr., Bigger J. T. [et al.]. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 2008;358(24):2545-2559. https://doi.org/10.1056/NEJMoa0802743
23. Riddle M. C. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation. 2010;122(8):844-846. https://doi.org/10.1161/CIRCULATIONAHA.110.960138
24. Accord Study Group. Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes. Diabetes Care. 2016;39(5):701-708. https://doi.org/10.2337/dc15-2283
25. Papanas N., Maltezos E. Oral antidiabetic agents: antiatherosclerotic properties beyond glucose lowering? Curr. Pharm. Des. 2009;15(27):3179-3192. https://doi.org/10.2174/138161209789057995
26. Ozaki Y., Yatomi Y., Kume S. Effects of oral hypoglycaemic agents on platelet functions. Biochem. Pharmacol. 1992;44(4):687-691. https://doi.org/10.1016/0006-2952(92)90404-7
27. Klaff L. J., Kernoff L., Vinik A. I., Jackson W. P. U., Jacobs P. Sulfonylureas and platelet function. Am. J. Med. 1981;70(3):627-630. https://doi.org/10.1016/0002-9343(81)90585-4
28. Kemeny S. F., Figueroa D. S., Clyne A. M. Hypo and hyperglycemia impair endothelial cell actin alignment and nitric oxide synthase activation in response to shear stress. PLoS One. 2013;8(6):e66176. https://doi.org/10.1371/journal.pone.0066176
29. Wright R. J., Macleod K. M., Perros P., Johnston N., Webb D. J., Frier B. M. Plasma endothelin response to acute hypoglycaemia in adults with Type 1 diabetes. Diabet. Med. 2007;24(9):1039-1042. https://doi.org/10.1111/j.1464-5491.2007.02199.x
30. Suh S. W., Gum E. T., Hamby A. M., Chan P. H., Swanson R. A. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J. Clin. Invest. 2007;117(4):910-918. https://doi.org/10.1172/JCI30077
31. Suh S. W., Hamby A. M., Gum E. T., Shin B. S., Won S. J. [et al.]. Sequential release ofnitric oxide, zinc, and superoxide inhypoglycemic neuronal death. J. Cereb. Blood Flow Metab. 2008;28(10):1697-1706. https://doi.org/10.1038/jcbfm.2008.61
32. Haces M. L., Montiel T., Massieu L. Selective vulnerability of brain regions to oxidative stress in a non-coma model of insulin-induced hypoglycemia. Neuroscience. 2010;165(1):28-38. https://doi.org/10.1016/j.neuroscience.2009.10.003
33. Patockova J., Marhol P., Tumova E., Krsiak M., Rokyta R. [et al.]. Oxidative stress in the brain tissue of laboratory mice with acute post insulin hypoglycemia. Physiol. Res. 2003;52(1):131-135.
34. McGowan J. E., Chen L., Gao D., Trush M., Wei C. Increased mitochondrial reactive oxygen species production in newborn brain during hypoglycemia. Neurosci. Lett. 2006;399(1-2):111-114. https://doi.org/10.1016/j.neulet.2006.01.034
35. Fuentes E., Palomo I. Role of oxidative stress on platelet hyperreactivity during aging. Life Sci. 2016;148:17-23. https://doi.org/10.1016/j.lfs.2016.02.026
36. Abbott N. J., Patabendige A. A., Dolman D. E., Yusof S. R., Begley D. J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010;37(1):13-25. https://doi.org/10.1016/j.nbd.2009.07.030
37. Hawkins B. T., Davis T. P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 2005;57(2):173-185. https://doi.org/10.1124/pr.57.2.4
38. Palmiotti C. A., Prasad S., Naik P., Abul K. M. D., Sajja R. K. [et al.]. In vitro cerebrovascular modeling in the 21st century: current and prospective technologies. Pharm. Res. 2014;31(12):3229-3250. https://doi.org/10.1007/s11095-014-1464-6
39. Garber A. J., Cryer P. E., Santiago J. V., Haymond M. W., Pagliara A. S., Kipnis D. M. The role of adrenergic mecha nisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J. Clin. Invest. 1976;58(1):7-15. https://doi.org/10.1172/JCI108460
40. Hilsted J., Bonde-Petersen F., Madsbad S., Parving H. H., Christensen N. J. [et al.]. Changes in plasma volume, in transcapillary escape rate of albumin and in subcutaneous blood flow during hypoglycaemia in man. Clin. Sci. 1985;69(3):273-277. https://doi.org/10.1042/cs0690273
41. Fisher B. M., Hepburn D. A., Smith J. G., Frier B. M. The effect of alpha-adrenergic blockade on responses of peripheral blood cells to acute insulin-induced hypoglycaemia in humans. Eur. J. Clin. Invest. 1990;20(1):51-55. https://doi.org/10.1111/j.1365-2362.1990.tb01790.x
42. Corrall R. J., Webber R. J., Frier B. M. Increase in coagulation factor VIII activity in man following acute hypoglycaemia: mediation via an adrenergic mechanism. Br. J. Haematol. 1980;44:301-305. https://doi.org/10.1111/j.1365-2141.1980.tb01212.x
43. Ibbotson S. H., Catto A., Davies J. A., Grant P. J. The effect of insulin-induced hypoglycaemia on factor VIII:C concentrations and thrombin activity in subjects with type 1 (insulin- dependent) diabetes. Thromb. Haemost. 1995;73(2): 243-246. https://doi.org/10.1055/s-0038-1653758
44. Hartley P. S., Savill J. S., Brown S. B. Hypoglycaemia predisposes platelets to death by affecting calcium homeostasis and mitochondrial integrity. Platelets. 2007;18(2):103-112. https://doi.org/10.1080/09537100600760822
45. Gogitidze Joy N., Hedrington M. S., Briscoe V. J., Tate D. B., Ertl A. C., Davis S. N. Effects of acute hypoglycemia on inflammatory and proatherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care. 2010;33(7):1529-1535. https://doi.org/10.2337/dc09-0354
46. Zharikov S., Shiva S. Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease. Biochem. Soc. Trans. 2013;41(1):118-123. https://doi.org/10.1042/BST20120327
47. Wright R. J., Newby D. E., Stirling D., Ludlam C. A., Macdonald I. A., Frier B. M. Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care. 2010;33(7):1591-1597. https://doi.org/10.2337/dc10-0013
48. Nematollahi R. L., Kitabchi A. E., Stentz F. B., Wan J. Y., Larijani B. A. [et al.]. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism. 2009;58(4):443-448. https://doi.org/10.1016/j.metabol.2008.10.018
49. Swystun L. L., Liaw P. C. The role of leukocytes in thrombosis. Blood. 2016;128(6):753-762. https://doi.org/10.1182/blood-2016-05-718114
50. Ghasemzadeh M., Hosseini E. Platelet-leukocyte crosstalk: linking proinflammatory responses to procoagulant state. Thromb. Res. 2013;131(3):191-197. https://doi.org/10.1016/j.thromres.2012.11.028
51. Freynhofer M. K., Bruno V., Wojta J., Huber K. The role of platelets in athero-thrombotic events. Curr. Pharm. Des. 2012;18(33):5197-5214. https://doi.org/10.2174/138161212803251899
52. Roquer J., Segura T., Serena J., Castillo J. Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc. Dis. 2009;27(Suppl.1):25-37. https://doi.org/10.1159/000200439
53. Cherian P., Hankey G. J., Eikelboom J. W., Thom J., Baker R. I. [et al.]. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke. 2003;34(9):2132-2137. https://doi.org/10.1161/01.STR.0000086466.32421.F4
54. Trovati M., Anfossi G., Cavalot F., Vitali S., Massucco P. [et al.]. Studies on mechanisms involved in hypoglycemia- induced platelet activation. Diabetes. 1986;35(7):818-825. https://doi.org/10.2337/diab.35.7.818
55. Joy N. G., Perkins J. M., Mikeladze M., Younk L., Tate D. B., Davis S. N. Comparative effects of acute hypoglycemia and hyperglycemia on pro-atherothrombotic biomarkers and endothelial function in non-diabetic humans. J. Diabetes Complications. 2016;30(7):1275-1281. https://doi.org/10.1016/j.jdiacomp.2016.06.030
Ключевые слова: сахарный диабет 2-го типа, гипогликемия, инсульт, пожилой и старческий возраст
Учредители:
Ставропольская государственная медицинская академия
Государственный научно-исследовательский институт курортологии
Пятигорская государственная фармацевтическая академия